Novartis Investigative Site

Manassas, Virginia 20110

0 studies enrolling now · 4 studies all time

What they study most

Acute Myocardial Infarction, Cardiovascular Disease and Lipoprotein(a), Chronic Obstructive Pulmonary Disease (COPD)

Studies at this site

• Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD — Running, not enrolling
• Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI — Completed
• Lipoprotein(a) in Patients With Cardiovascular Disease (CVD) — Completed
• Long Term Safety Study of NVA237 vs QAB149 in COPD Patients — Completed